trending Market Intelligence /marketintelligence/en/news-insights/trending/ywztxOrkTQM-dduMas1eEg2 content esgSubNav
In This List

Global Blood Therapeutics adds director

Blog

Insight Weekly: Ukraine war impact on mining; US bank growth slowdown; cloud computing headwinds

Blog

Insight Weekly: Cryptocurrency's growth; green bond market outlook; coal investors' windfall

Blog

Global M&A By the Numbers: Q1 2022

Blog

Insight Weekly: Challenges for European banks; Japan's IPO slowdown; carmakers' supply woes


Global Blood Therapeutics adds director

Global Blood Therapeutics Inc. appointed Dawn Svoronos to its board.

Svoronos serves on the boards of Endocyte Inc., PTC Therapeutics Inc., Theratechnologies Inc. and Xenon Pharmaceuticals Inc. Previously, she acted as director and interim chief commercial officer of Medivation Inc. In addition, she was president of Merck Canada Inc.

South San Francisco, Calif.-based Global Blood Therapeutics is a clinical-stage biopharmaceutical company developing two therapies for the potential treatment of sickle cell disease.